119 воды из квартирных водоразборов // Военная медицина. №2/2012. С. 93 97

122
24. 
Liu
, H, Lee SS. Nuclear factor-kappa B inhibition improves 
myocardial contractility in rats with cirrhotic cardiomyopathy. Liver 
Int.- 2008.-28.-P.640–648. 
25
. Lin
, RS, Lee FY, Lee SD et al. Endotoxemia in patients with 
chronic liver diseases: relationship to severity of liver diseases, 
presence of esophageal varices, and hyperdynamic circulation. J 
Hepatol.- 1995.-22.-P.165–172.
26
. Ma
, Z, Lee SS. Cirrhotic cardiomyopathy: getting to the 
heart of the matter. Hepatology.- 1996.- 24.- P.451-459.
27
. Liu
, H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. 
J Gastroenterol Hepatol.- 1999.- 14.-P.600-608.
28.
 Zhong
, J, Hwang TC, Adams HR et al. Reduced L-type 
calcium current in ventricular myocytes from endotoxemic guinea 
pigs. Am J Physiol.- 1997.- 273.-P.2312–2324. 
29. 
Gould
, L, Shariff M, Zahir M et al. Cardiac hemodynamics 
in alcoholic patients with chronic liver disease and a presystolic
gallop. J Clin Invest.- 1969.-48.-P. 860–868
30.
 Kelbaek,
H, Eriksen J, Brynjolf I et al. Cardiac performance 
in patients with asymptomatic alcoholic cirrhosis of the liver. Am J 
Cardiol.- 1984.-54.-P.852–855.
31.
 Ruiz-del-Arbol,
L, Urman J, Fernandez J et al. Systemic, 
renal, and hepatic hemodynamic derangement in cirrhotic patients 
with spontaneous bacterial peritonitis. Hepatology.- 2003.-38.-
P.1210–1218.
32
. Ruiz-del-Arbol,
L, Monescillo A, Arocena C et al. Circulatory 
function and hepatorenal syndrome in cirrhosis. Hepatology.- 
2005.-42. – P.439–447.
33.
 Bernardi
, M, Rubboli A, Trevisani F et al. Reduced 
cardiovascular responsiveness to exercise-induced 
sympathoadrenergic stimulation in patients with cirrhosis. J 
Hepatology.- 1991.-12.-P.207–216. 
34.
F
Wong, P Liu, L Blendis. Sodium homeostasis with 
chronic sodium loading in preascitic cirrhosis. Gut.- 2001.-49.-
P.847–851.
35. 
Pozzi,
M, Grassi G, Ratti et al. Cardiac, neuroadrenergic, 
and portal hemodynamic effects of prolonged aldosterone 
blockade in postviral child A cirrhosis. Am J Gastroenterol.- 2005.-
100.-P. 1110–1116.
36.
Pitt
, B, Zannad F, Remme WJ et al. The effect of 
spironolactone on morbidity and mortality in patients with 
severe heart failure. Randomized Aldactone Evaluation Study 
Investigators. N Engl J Med.- 1999.-341.-P.709–717.
Поступила 28.01.2013 г. 
А.П. Шепелькевич

жүктеу/скачать 164,87 Kb.

Достарыңызбен бөлісу: